Authors' Reply to Hays: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance"
Appl Health Econ Health Policy
.
2020 Jun;18(3):459-460.
doi: 10.1007/s40258-020-00573-w.
Authors
David J Mott
1
,
Grace Hampson
2
,
Martin J Llewelyn
3
,
Jorge Mestre-Ferrandiz
2
4
,
Michael M Hopkins
5
Affiliations
1
Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, UK.
[email protected]
.
2
Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, UK.
3
Brighton and Sussex Medical School, Brighton, UK.
4
Independent Economics Consultant, Madrid, Spain.
5
Science Policy Research Unit, University of Sussex Business School, Jubilee Building, Falmer, Brighton, UK.
PMID:
32201931
DOI:
10.1007/s40258-020-00573-w
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents
Drug Resistance, Bacterial*
Humans
Patient Preference*
Substances
Anti-Bacterial Agents
Grants and funding
MR/N014316/1/MRC_/Medical Research Council/United Kingdom